dementia | GenomeWeb

dementia

The firm is leveraging its broad network and deep diagnostics test portfolio to provide integrated solutions around clinical problems.

The companies said they aim to discover next-generation tests that will enable early diagnosis of dementia, as well as treatment selection and monitoring.

Five research teams from the University of British Columbia and Simon Fraser University will split the funding.

NEW YORK (GenomeWeb) – The Medical Research Council on Thursday announced a £16 million ($27 million) research project into dementia that includes the development of new biomarkers for identifying those at risk for developing the condition and patients who may be candidates for new drug trials.

NEW YORK (GenomeWeb News) – Dementia diagnostics firm Cytox today said that it raised £1.5 million ($2.5 million) in a second round of funding.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.

By Adam Bonislawski
A Stanford University-led research team has identified plasma proteins linked to declines in neurogenesis and impaired learning and memory.

The Center for Genomics and Transcriptomics is now offering sequencing-based diagnostic tests for epilepsy, dementia, amyotrophic lateral sclerosis, Parkinson's disease, and hereditary eye diseases, joining a small but growing number of organizations offering diagnostic panels on next-generation sequencing platforms.

Researchers from the University of Pennsylvania and elsewhere used a genome-wide association study of post-mortem patient tissues to find genetic variants linked to frontotemporal lobar degeneration.

WSU and the Michigan Technology and Research Institute are seeking funding to form a company to shepherd to clinical trials WSU's first candidate, a triple uptake inhibitor for treating depression. They eventually hope to attract a pharma partner for further development.

Pages

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.